Follow us on X @opticianonline
NEWS IN BRIEF
Week of charitable activity planned at Suzanne Dennis Optometrist An independent in the Nor th-West is hosting a week-long special event at its three practices to raise awareness and funds for a local charity.
Suzanne Dennis Optometrist’s practices in Parbold, Standish and Eccleston were suppor ting the Natalie Kate Moss Trust from October 14-19.
Workshops will be held all week to monitor blood pressure and provide education around brain haemorrhages, as well as raffles and a Tom Ford eyewear showcase.
Joe Higham, co-director of the three practices, said: ‘The charity links to what we do, in terms of looking at the posterior of the eye and the health of the blood vessels, which can indicate things like high blood pressure.
‘There’s evidence to suggest that we can see changes to blood vessels up to four years before any symptoms appear. We can look at an eye and as a result, recommend that someone goes for a blood pressure check.
‘All this links to the fundamentals of the charity, so we wanted to be par t of the drive to provide awareness and education around brain haemorrhages, while suppor ting a local charity.’
The independent will donate £50 to the charity for ever y frame purchase over the value of £399 during the week and patients
Suzanne Dennis Optometrist staff running for the Natalie Kate Moss Trust will be incentivised with an offer of free lens upgrades during the week.
Staff at Suzanne Dennis Optometrist completed a 10k run in Manchester earlier in the year and plans are being made to run a half marathon in Paris next year as par t of its fundraising activity.
performing tonometry and 82% recommended the tool.
EssilorLuxottica extends Meta partnership EssilorLuxottica has extended its partnership with Meta Platforms and will continue to develop multigenerational smart eyewear products.
The two companies first partnered in 2019 and have launched two generations of Ray-Ban branded smart glasses in the US, UK, Australia and across Europe.
‘The incredible work we’ve done with Meta, still in its early stages, has already proven to be an important milestone in our journey to making glasses the gateway to the connected world,’ said Francesco Milleri, chair and CEO at EssilorLuxottica.
Meta Ray-Ban
Mark Zuckerberg, founder and CEO of Meta, added he was excited about the long-term partnership with EssilorLuxottica and the opportunity to turn frames into the next major technology platform.
Marcolin makes key appointments Marcolin has made two appointments to support the growth of its luxury brands and commitment to providing exceptional service to its customers.
Simone Wray has joined as representative in Greater London for Tom Ford, Zegna and Max Mara and Marcolin said her experience in the region would strengthen the position of its premium brands.
Jen Efremova has joined as a senior key account manager for UK and Eire and has a background in the fashion industry, including at Stella McCartney.
She will be the primary contact for on and offline accounts and have a key role in delivering growth across the entire Marcolin portfolio within all commercial channels.
Groundbreaking study into FECD Advanced optical genome mapping has been used to identify how vision-loss disease Fuchs
Simone Wray, Marcolin endothelial corneal dystrophy (FECD) progresses and potential therapeutic developments.
A study, published in eBioMedicine journal and led by the UCL Institute of Ophthalmology, revealed that understanding the mechanisms behind FECD was key to developing new treatments for FECD and other diseases related to genetic mutations.
Findings of those with FECD highlighted the significance of the extreme genetic instability on a molecular level that enables a high frequency of mutations, which was heavily impacted by both size and patient age.
It said that a key factor in developing FECD is the expansion of a specific DNA sequence within the TCF4 gene, called CTG18.1, and researchers aimed to develop further experiments to examine how and when this genetic change happens.
Glaucoma research awarded Glaucoma UK and the Royal College of Ophthalmologists have granted its 2024 research award to Dr Lisa Hill and Dr Victoria McGilligan for two projects to the total of nearly £200,000.
Dr Lisa Hill at the University of Birmingham has received £99,652 towards the development of a treatment for primary open angle glaucoma by targeting the prevention and treatment of extracellular matrix ECM dysfunction.
Dr Victoria McGilligan at Ulster University has been awarded £99,919 to develop a bispecific antibody therapy targeting the NLRP3 inflammasome for glaucoma, which is said to potentially stop glaucoma progression, offering a new treatment approach beyond just lowering eye pressure.
opticianonline.net
27 September 2024 OPTICIAN 5
